Literature DB >> 23397353

Eliminating mother-to-child HIV transmission in South Africa.

Peter Barron1, Yogan Pillay, Tanya Doherty, Gayle Sherman, Debra Jackson, Sanjana Bhardwaj, Precious Robinson, Ameena Goga.   

Abstract

PROBLEM: The World Health Organization has produced clear guidelines for the prevention of mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV). However, ensuring that all PMTCT programme components are implemented to a high quality in all facilities presents challenges. APPROACH: Although South Africa initiated its PMTCT programme in 2002, later than most other countries, political support has increased since 2008. Operational research has received more attention and objective data have been used more effectively. LOCAL
SETTING: In 2010, around 30% of all pregnant women in South Africa were HIV-positive and half of all deaths in children younger than 5 years were associated with the virus. RELEVANT CHANGES: Between 2008 and 2011, the estimated proportion of HIV-exposed infants younger than 2 months who underwent routine polymerase chain reaction (PCR) tests to detect early HIV transmission increased from 36.6% to 70.4%. The estimated HIV transmission rate decreased from 9.6% to 2.8%. Population-based surveys in 2010 and 2011 reported transmission rates of 3.5% and 2.7%, respectively. LESSONS LEARNT: CRITICAL ACTIONS FOR IMPROVING PROGRAMME OUTCOMES INCLUDED: ensuring rapid implementation of changes in PMTCT policy at the field level through training and guideline dissemination; ensuring good coordination with technical partners, such as international health agencies and international and local nongovernmental organizations; and making use of data and indicators on all aspects of the PMTCT programme. Enabling health-care staff at primary care facilities to initiate antiretroviral therapy and expanding laboratory services for measuring CD4+ T-cell counts and for PCR testing were also helpful.

Entities:  

Mesh:

Year:  2012        PMID: 23397353      PMCID: PMC3537246          DOI: 10.2471/BLT.12.106807

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Improving public health information: a data quality intervention in KwaZulu-Natal, South Africa.

Authors:  W Mphatswe; K S Mate; B Bennett; H Ngidi; J Reddy; P M Barker; N Rollins
Journal:  Bull World Health Organ       Date:  2011-12-05       Impact factor: 9.408

2.  Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa.

Authors:  Tanya Doherty; Mickey Chopra; Duduzile Nsibande; Dudu Mngoma
Journal:  BMC Public Health       Date:  2009-11-05       Impact factor: 3.295

3.  Challenges for routine health system data management in a large public programme to prevent mother-to-child HIV transmission in South Africa.

Authors:  Kedar S Mate; Brandon Bennett; Wendy Mphatswe; Pierre Barker; Nigel Rollins
Journal:  PLoS One       Date:  2009-05-12       Impact factor: 3.240

  3 in total
  69 in total

Review 1.  The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.

Authors:  Shabir A Madhi; Marta C Nunes
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Antiretroviral Treatment and Resistance Patterns in HIV-Infected Children.

Authors:  Olatunji Adetokunboh; Oluyemi Atibioke; Tolulope Balogun; Mojisola Oluwasanu
Journal:  Curr Infect Dis Rep       Date:  2015-10       Impact factor: 3.725

3.  Birth size and early pneumonia predict linear growth among HIV-exposed uninfected infants.

Authors:  Emily L Deichsel; Patricia B Pavlinac; Barbra A Richardson; Dorothy Mbori-Ngacha; Judd L Walson; Christine J McGrath; Carey Farquhar; Rose Bosire; Elizabeth Maleche-Obimbo; Grace C John-Stewart
Journal:  Matern Child Nutr       Date:  2019-08-06       Impact factor: 3.092

4.  A Bayesian Analysis of Prenatal Maternal Factors Predicting Nonadherence to Infant HIV Medication in South Africa.

Authors:  R R Cook; K Peltzer; S M Weiss; V J Rodriguez; D L Jones
Journal:  AIDS Behav       Date:  2018-09

5.  Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa.

Authors:  Landon Myer; Tamsin Phillips; Victoria Manuelli; James McIntyre; Linda-Gail Bekker; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-26       Impact factor: 3.731

6.  12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.

Authors:  Karl-Günter Technau; Renate Strehlau; Faeezah Patel; Stephanie Shiau; Megan Burke; Martie Conradie; Gillian Sorour; Gayle G Sherman; Ashraf Coovadia; Pamela M Murnane; Elaine J Abrams; Louise Kuhn
Journal:  Lancet HIV       Date:  2018-11-08       Impact factor: 12.767

Review 7.  A Political and Social History of HIV in South Africa.

Authors:  Nono Simelela; W D Francois Venter; Yogan Pillay; Peter Barron
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

8.  Empowering patients to link to care and treatment: qualitative findings about the role of a home-based HIV counselling, testing and linkage intervention in South Africa.

Authors:  Lucia C Knight; Heidi Van Rooyen; Hilton Humphries; Ruanne V Barnabas; Connie Celum
Journal:  AIDS Care       Date:  2015-04-29

9.  Southern Africa: the Highest Priority Region for HIV Prevention and Care Interventions.

Authors:  Sten H Vermund; Emily K Sheldon; Mohsin Sidat
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

10.  Development and implementation challenges of a quality assured HIV infant diagnosis program in Nigeria using dried blood spots and DNA polymerase chain reaction.

Authors:  Rosemary Audu; Chika Onwuamah; Olumuyiwa Salu; Azuka Okwuraiwe; Chin-Yih Ou; Omotayo Bolu; Kyle B Bond; Karidia Diallo; Lydia Lu; Tapdiyel Jelpe; McPaul Okoye; Evelyn Ngige; John Vertefeuille
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.